Skip to content
PEPTALK
All comparisons

Retatrutide vs TB-500 (Thymosin Beta-4)

Comparing self-reported PepTalk data: Retatrutide does not have enough reports yet to show a cohort figure (n=0), while TB-500 (Thymosin Beta-4) does not have enough reports yet to show a cohort figure (n=0).

Retatrutide

GLP-1 / Incretin Agonists

Contributors (n)0
Data points0
Median doseNot enough data
Top reported side effects

Not enough data yet.

TB-500 (Thymosin Beta-4)

Healing & Recovery Peptides

Contributors (n)0
Data points0
Median doseNot enough data
Top reported side effects

Not enough data yet.

Self-reported by users, unverified. Not medical advice and not an endorsement of any substance. 18+ only.